ACIN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.770400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.147400E-01
Normal-vs-Stage2
5.683600E-02
Normal-vs-Stage3
9.414400E-02
Normal-vs-Stage4
3.425000E-01
Stage1-vs-Stage2
7.212600E-01
Stage1-vs-Stage3
1.082570E-01
Stage1-vs-Stage4
8.049800E-01
Stage2-vs-Stage3
4.990000E-02
Stage2-vs-Stage4
9.577800E-01
Stage3-vs-Stage4
2.396000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.866300E-02
Normal-vs-AfricanAmerican
3.076000E-01
Normal-vs-Asian
1.675630E-01
Caucasian-vs-AfricanAmerican
4.179200E-01
Caucasian-vs-Asian
8.952200E-01
AfricanAmerican-vs-Asian
5.292400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.779700E-02
Normal-vs-Female
6.313700E-02
Male-vs-Female
6.351400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.599600E-01
Normal-vs-Age(41-60Yrs)
4.585600E-01
Normal-vs-Age(61-80Yrs)
6.129600E-02
Normal-vs-Age(81-100Yrs)
1.624420E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.083200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.935400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.452800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.593900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.003200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.770000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.422200E-02
Normal-vs-Daily Drinker
1.021640E-01
Normal-vs-Weekly Drinker
2.065000E-01
Normal-vs-Occasional Drinker
2.245000E-01
Normal-vs-Social Drinker
1.301780E-01
Non Drinker-vs-Daily Drinker
4.945400E-01
Non Drinker-vs-Weekly Drinker
5.185600E-01
Non Drinker-vs-Occasional Drinker
1.825970E-01
Non Drinker-vs-Social Drinker
3.929800E-01
Daily Drinker-vs-Weekly Drinker
9.233200E-01
Daily Drinker-vs-Occasional Drinker
4.758000E-01
Daily Drinker-vs-Social Drinker
8.078400E-01
Weekly Drinker-vs-Occasional Drinker
6.269000E-01
Weekly Drinker-vs-Social Drinker
9.156200E-01
Occasional Drinker-vs-Social Drinker
6.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.610400E-01
Normal-vs-Grade 2
6.874400E-01
Normal-vs-Grade 3
6.653000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.202800E-01
Grade 1-vs-Grade 3
7.704400E-01
Grade 1-vs-Grade 4
2.610400E-01
Grade 2-vs-Grade 3
5.458800E-01
Grade 2-vs-Grade 4
6.874400E-01
Grade 3-vs-Grade 4
6.653000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.810200E-02
Normal-vs-NonDiabetic
6.794000E-02
Diabetic-vs-NonDiabetic
4.384800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.404400E-01
Normal-vs-NoPancreatitis
5.083600E-02
Pancreatitis-vs-NoPancreatitis
6.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.458100E-02
Normal-vs-N1
5.137700E-02
N0-vs-N1
5.943000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.334400E-01
Normal-vs-TP53-NonMutant
2.014800E-01
TP53-Mutant-vs-TP53-NonMutant
9.630000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
